Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Recruiting in Palo Alto (17 mi)

+157 other locations

Overseen bySmita Bhatia

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Children's Oncology Group

No Placebo Group

Trial Summary

What is the purpose of this trial?

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Research Team

Smita Bhatia

Principal Investigator

Children's Oncology Group

Eligibility Criteria

Inclusion Criteria

The patient must reside in the U.S. on the date of enrollment to ALTE05N1

All patients and/or their parents or legal guardians must sign a written informed consent

All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be me

Treatment Details

Interventions

Assessment of Therapy Complications (Procedure)
Questionnaire Administration (Behavioural Intervention)

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Observational (long-term follow-up)Experimental Treatment2 Interventions

Within 3 months of enrollment on ALTE05N1, patients receive a packet introducing the Long-Term Follow-Up Center (LTFC). Patients are asked to complete a patient response form, verify information provided in packet, and update contact and health status information. The Health Status Update Form is a brief document including questions about current health status, disease status, and cancer therapy received since the last mailing. Patients may respond by use of postage prepaid envelopes, secure online form, or 24-hour toll-free telephone number. After initial contact, the LTFC will contact the patient annually